The A-HIRATE Trial was a multicenter, prospective study assessing the incidence of atrial high rate episodes (AHRE) in pacemaker patients with and without previously diagnosed AT. The trial was ...

Atrial fibrillation (AFib) is an irregular and often rapid heart rhythm. The terms “controlled AFib” and “uncontrolled AFib” describe whether treatment strategies are effectively managing ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

The atrial fibrillation device market is heavily influenced by rapid technological innovations. Devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, and catheter ablation ...

Pacemakers are typically recommended for patients with certain heart conditions, including: Bradycardia: Abnormally slow heart rate ... The body’s own electrical system is unable to initiate heart ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...

Onset of AHRE differed between patient subgroups. The incidence of AHRE that initiated as bradycardia was higher in patients without prior AT history (28.1% vs 9.3%, P < 0.0001) while the majority ...

Neonatal bradycardia is characterised by a heart rate below 80 bpm, irrespective of gestational age. It is generally self-resolving but, in some cases, represents an underlying pathology which may be ...